Phase II trial of second selective S1P1 receptor modulator in patients with systemic lupus erythematosus

Trial Profile

Phase II trial of second selective S1P1 receptor modulator in patients with systemic lupus erythematosus

Planning
Phase of Trial: Phase II

Latest Information Update: 22 Apr 2015

At a glance

  • Drugs Cenerimod (Primary)
  • Indications Systemic lupus erythematosus
  • Focus Therapeutic Use
  • Sponsors Actelion Pharmaceuticals
  • Most Recent Events

    • 22 Apr 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top